Shionogi & Co Ltd

Highly Engaged Employees

Shionogi & Co Ltd, established in 1878, is a prominent Japanese pharmaceutical company dedicated to pioneering innovative treatments that significantly improve patient lives globally. The company's core mission revolves around addressing critical unmet medical needs, with a strong historical and ongoing focus on infectious diseases. This includes the discovery and development of novel therapies for bacterial infections, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi leverages a robust research-driven approach, combining extensive in-house R&D capabilities with strategic collaborations across diverse sectors, including industry partners, government agencies, biotech firms, and academic institutions. This integrated strategy accelerates the advancement of its scientific pipeline and ensures the timely delivery of essential medicines.

Operating with a global perspective, Shionogi employs between 1,000 and 5,000 individuals across its 10 locations. The company generates substantial revenue, reported at $1.7B, underscoring its significant market presence. Its commitment to innovation extends to its operational structure and team, aiming to bring meaningful therapies to patients with urgency and precision. To learn more about the individuals driving these efforts, one can Meet Shionogi & Co Ltd's team. The company's product portfolio is centered on research-driven pharmaceuticals, emphasizing drug discovery and commercialization for critical diseases.

Within the competitive landscape of the Pharmaceuticals and Healthcare industries, Shionogi & Co Ltd competes with entities such as PRA Health Sciences, Medpace, and Neurocrine Biosciences, among others. Its strategic focus on developing novel treatments for infectious diseases positions it as a key player in global health security and patient care. The company's long-standing history andView more...